Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FQTF8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,896
Award facts
- Contract value 100% obligated
- $7,896.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on June 15, 2026, with a ceiling value of $7,896.10 for XOLAIR 150 MG/ML syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical is a woman-owned small business. Place of performance is Park Ridge, IL. The order carries an ultimate completion date of July 8, 2026. Pricing is firm fixed price with no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26FQTF8?
SPE2DR26FQTF8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 15, 2026.
How much is contract SPE2DR26FQTF8 worth?
The government has obligated $7,896 on SPE2DR26FQTF8.
Is contract SPE2DR26FQTF8 an order under another contract?
Yes. SPE2DR26FQTF8 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQTF8 competed?
The extent of competition for SPE2DR26FQTF8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award